DARATUMUMAB-BASED COMBINATION THERAPIES IN HEAVILY-PRE-TREATED PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Lakshman, A. [1 ]
Abeykoon, J. [2 ]
Kumar, S. [1 ]
Rajkumar, V. [1 ]
Kourelis, T. [1 ]
Buadi, F. [1 ]
Dingli, D. [1 ]
Martha, L. [1 ]
Gonsalves, W. [1 ]
Dispenzieri, A. [1 ]
Kyle, R. [1 ]
Lin, Y. [1 ]
Go, R. [1 ]
Warsame, R. [1 ]
Hobbs, M. [1 ]
Fonder, A. [1 ]
Hwa, Y. [1 ]
Hayman, S. [1 ]
Russell, S. [1 ]
Leung, N. [1 ]
Gertz, M. [1 ]
Kapoor, P. [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Mayo Clin, Internal Med, Rochester, MN USA
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1240
引用
收藏
页码：508 / 508
页数：1
相关论文
共 50 条
  • [1] Daratumumab-based combination therapies (DCT) in heavily-pretreated patients (pts) with relapsed and/or refractory multiple myeloma (RRMM).
    Lakshman, Arjun
    Abeykoon, Jithma P.
    Kumar, Shaji
    Rajkumar, S. Vincent
    Kourelis, Taxiarchis
    Buadi, Francis
    Dingli, David
    Lacy, Martha
    Gonsalves, Wilson I.
    Dispenzieri, Angela
    Kyle, Robert A.
    Lin, Yi
    Go, Ronald S.
    Warsame, Rahma M.
    Hayman, Suzanne R.
    Russell, Stephen
    Leung, Nelson
    Gertz, Morie A.
    Kapoor, Prashant
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials
    Lakshman, Arjun
    Abeykoon, Jithma P.
    Kumar, Shaji K.
    Rajkumar, S. Vincent
    Dingli, David
    Buadi, Francis K.
    Gonsalves, Wilson I.
    Leung, Nelson
    Dispenzieri, Angela
    Kourelis, Taxiarchis V.
    Go, Ronald S.
    Lacy, Martha Q.
    Hobbs, Miriam A.
    Lin, Yi
    Warsame, Rahma
    Lust, John
    Fonder, Amie L.
    Hwa, Yi L.
    Hayman, Suzanne R.
    Russell, Stephen J.
    Kyle, Robert A.
    Gertz, Morie A.
    Kapoor, Prashant
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (11) : 1146 - 1155
  • [3] Cost-effectiveness of Daratumumab-based Triplet Therapies in Patients With Relapsed or Refractory Multiple Myeloma
    Zhang, Tian-tian
    Wang, Sen
    Wan, Ning
    Zhang, Li
    Zhang, Zugui
    Jiang, Jie
    CLINICAL THERAPEUTICS, 2018, 40 (07) : 1122 - 1139
  • [4] Role of Daratumumab in Combination With Standard Therapies in Patients With Relapsed and Refractory Multiple Myeloma
    Bapatla, Anusha
    Kaul, Arunima
    Dhalla, Paramvijay Singh
    Armenta-Quiroga, Ana S.
    Khalid, Raheela
    Garcia, Jian
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [5] Daratumumab-Based Regimens with Prior Carfilzomib in Patients with Relapsed Refractory Multiple Myeloma (RRMM)
    Tungesvik, Alexandre
    Huang, Jessica
    Sudalagunta, Praneeth
    Dimaggio, Elizabeth
    De Avila, Gabe
    Tandon, Ankita
    Nelson, Rebeccah
    Olson, Laura
    Tobon, Katherine
    Shain, Kenneth
    Brayer, Jason
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S327 - S328
  • [6] Bendamustine in heavily pre-treated patients with relapsed or refractory multiple myeloma
    Stoehr, Elisabeth
    Schmeel, Frederic Carsten
    Schmeel, Leonard Christopher
    Haenel, Mathias
    Schmidt-Wolf, Ingo G. H.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (12) : 2205 - 2212
  • [7] Bendamustine in heavily pre-treated patients with relapsed or refractory multiple myeloma
    Elisabeth Stöhr
    Frederic Carsten Schmeel
    Leonard Christopher Schmeel
    Mathias Hänel
    Ingo G. H. Schmidt-Wolf
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 2205 - 2212
  • [8] Response Kinetics of Daratumumab-Based Regimens in Patients with Newly Diagnosed or Refractory/Relapsed Multiple Myeloma
    Wang, Jiasheng
    Arroyo-Suarez, Raul
    Tse, William
    BLOOD, 2021, 138 : 3806 - +
  • [9] Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma
    Ziccheddu, Bachisio
    Giannotta, Claudia
    D'Agostino, Mattia
    Bertuglia, Giuseppe
    Saraci, Elona
    Oliva, Stefania
    Genuardi, Elisa
    Papadimitriou, Marios
    Diamond, Benjamin
    Corradini, Paolo
    Coffey, David
    Landgren, Ola
    Bolli, Niccolo
    Bruno, Benedetto
    Boccadoro, Mario
    Massaia, Massimo
    Maura, Francesco
    Larocca, Alessandra
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [10] Daratumumab monotherapy in heavily pretreated Asians patients with relapsed and refractory multiple myeloma
    Yoon, Sung-Soo
    Byun, Ja Min
    Park, Hyunkyung
    Lee, Ji Yun
    Koh, Youngil
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E155 - E156
12345